MarketCap
Facebook
X
TelegramGenMark Diagnostics, Inc. Market Cap | GNMK
As of October 26, 2026 GenMark Diagnostics, Inc. has a market cap of $ 1.77 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 933 M | 317 M | 361 M | 271 M | 523 M | 223 M | 533 M | 441 M | 279 M | 74.4 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 933 M | 74.4 M | 395 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cognyte Software Ltd.
CGNT
|
591 M | $ 10.09 | 3.38 % | $ 736 M |  Israel |
 |
Electromed
ELMD
|
325 M | $ 26.86 | 2.05 % | $ 222 M |  USA |
 |
Establishment Labs Holdings
ESTA
|
2.31 B | $ 66.58 | 4.35 % | $ 1.97 B |  Costa-rica |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.74 | -0.75 % | $ 12.5 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 89.91 | 0.91 % | $ 52.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
4.03 B | $ 2.23 | -1.33 % | $ 49.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 23.71 | -3.22 % | $ 556 M | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 3.87 | -1.02 % | $ 572 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | - | - | $ 162 M |  France |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Avanos Medical
AVNS
|
628 M | $ 24.99 | - | $ 1.16 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
89.5 M | - | - | $ 140 M | USA |
 |
GBS
GBS
|
248 K | - | -0.57 % | $ 7.12 M | USA |
 |
NanoVibronix
NAOV
|
92 K | - | - | $ 1.08 M | USA |
 |
Ra Medical Systems
RMED
|
1.49 M | - | 10.0 % | $ 610 K | USA |
 |
ReWalk Robotics Ltd.
RWLK
|
768 K | - | 7.07 % | $ 66.1 M | Israel |
 |
STRATA Skin Sciences
SSKN
|
34 M | - | - | $ 6.6 M | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 9.7 | -1.12 % | $ 384 M |  Curacao |
 |
TransMedics Group
TMDX
|
4.69 B | $ 71.03 | 0.41 % | $ 2.41 B | USA |
 |
Aethlon Medical
AEMD
|
1.36 M | $ 5.05 | 1.78 % | $ 3.4 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 38.31 | 0.64 % | $ 1.76 B | USA |
 |
Nevro Corp.
NVRO
|
213 M | - | - | $ 217 M | USA |
 |
Venus Concept
VERO
|
1.84 M | - | - | $ 726 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Sientra
SIEN
|
20.9 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
683 M | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
11.4 M | - | -32.98 % | $ 1.68 M | USA |
 |
Butterfly Network
BFLY
|
946 M | $ 6.78 | 0.37 % | $ 1.68 B | USA |
 |
Cardiovascular Systems
CSII
|
602 M | - | 0.15 % | $ 844 M | USA |
 |
ShockWave Medical
SWAV
|
9.61 B | - | - | $ 12.3 B | USA |
 |
Inari Medical
NARI
|
3.07 B | - | - | $ 4.23 B | USA |
 |
Abiomed
ABMD
|
16.2 M | - | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.38 M | - | 3.58 % | $ 2.21 M | USA |
 |
Titan Medical
TMDI
|
115 M | - | -26.32 % | $ 19.6 M |  Canada |
 |
Natus Medical Incorporated
NTUS
|
799 M | - | 1.94 % | $ 1.05 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
ThermoGenesis Holdings
THMO
|
2.09 M | - | -25.84 % | $ 171 K | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Talis Biomedical Corporation
TLIS
|
15.9 M | - | 3.55 % | $ 7.96 M | USA |
 |
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | USA |